Experience with recombinant human thyrotrophin in the management of differentiated thyroid cancer (DTC).

被引：0
|
作者：
Mariani, G
Ferdeghini, M
Augeri, C
Villa, G
Taddei, GZ
Scopinaro, G
Boni, G
Bellina, CR
Rabitti, C
Molinari, E
Bianchi, R
机构：
[1] Univ Genoa, Genoa, Italy
[2] Univ Pisa, Pisa, Italy
[3] Galliera Hosp, Genoa, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
926
引用
收藏
页码：207P / 207P
页数：1
相关论文
共 50 条
  • [31] Using recombinant human TSH in the management of well-differentiated thyroid cancer: Current strategies and future directions
    Mazzaferri, EL
    Kloos, RT
    [J]. THYROID, 2000, 10 (09) : 767 - 778
  • [32] Acute effects of recombinant human TSH on bone markers in differentiated thyroid cancer
    Iakovou, Ioannis
    Chrisoulidou, Alexandra
    Balaris, Vassilis
    Balaris, Christos
    Doumas, Argyrios
    Karatzas, Nikolaos
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2010, 13 (03): : 208 - 212
  • [33] THE ROLE OF RECOMBINANT HUMAN THYROTROPIN FOR DIAGNOSTIC MONITORING OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Sherman, Steven I.
    [J]. ENDOCRINE PRACTICE, 2013, 19 (01) : 157 - 161
  • [34] Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
    Luster, Markus
    Schlumberger, Martin
    Pacini, Furio
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (02) : 329 - 330
  • [35] Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer
    Pacini, Furio
    Castagna, Maria Grazia
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (06) : 1009 - 1021
  • [36] Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
    Markus Luster
    Martin Schlumberger
    Furio Pacini
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 329 - 330
  • [37] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40
  • [38] Radioiodine imaging (WBS) and serum thyroglobulin(TG) in management of thyroid cancer (DTC): Randomised study with recombinant human TSH (rhTSH) and without thyroid hormone
    Bertolazzi, L
    Zoccola, R
    Giusti, M
    Villa, G
    Scattina, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1209 - 1209
  • [39] Radioiodine thyroid remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC): Impact of recombinant human thyroid-stimulating hormone (rhTSH) on treatment room length-of-stay and utilization
    Antonio Vallejo, Juan
    Mena, Luisa
    Angeles Galvez, Maria
    Marlowe, Robert
    Latre, Jose
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [40] Recombinant human thyrotropin versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer: Experience in a South Taiwanese medical center
    Tsai, Jia-Ruei
    Wu, Shu-Ting
    Chi, Shun-Yu
    Yang, Yi-Ting
    Chan, Yi-Chia
    Lim, Lay San
    Chiew, Yvonne Ee Wern
    Chen, Wen-Chieh
    Chen, Yung-Nien
    Chou, Chen-Kai
    [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (02): : 175 - 181
12345